Development of novel platforms for cancer immunotherapy
The IVTLab is an international and interdisciplinary laboratory promoting cutting-edge research in the field of oncoimmunology and immunotherapy using viruses as platforms to induce and/or orchestrate the tumor-specific immune response. The laboratory is well supported and funded by prestigious and internationally recognised funding agencies such as the European Research Council Consolidator grant (ERC-CoG), HiLIFE, Jane and Aatos Erkko Foundation and Business Finland.
Twitter and News
How Viruses Could Cure Cancer and Save Lives
“When a virus is given to a tumor, the tumor becomes infected tissue,” says Vincenzo Cerullo, an oncolytic cancer vaccine immunologist at the...
Immunotherapy among innovation, vanguard and creativity: Prof. Vincenzo Cerullo and his experience in Helsinki
Immunotherapy has revolutionized the treatment of many cancers and research continues to make progress to find increasingly effective treatments...
PeptiCHIP is a novel microchip-based solution that enables rapid, accurate, user-friendly and standardized tumor...
Members of the ImmunoViroTherapy Lab
The group consists of many experts and researchers with outstanding knowledge in the field of immunovirotherapy.
One of my main priorities is promoting science to non-scientific audience and I believe that it has never been a better time then now to do...